DAPAGLIFLOZIN- COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1295
https://www.valueinhealthjournal.com/article/S1098-3015(16)01363-2/fulltext
Title : DAPAGLIFLOZIN- COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01363-2&doi=10.1016/j.jval.2016.03.1295
First page : A202
Section Title : Diabetes/Endocrine Disorders - Cost Studies
Open access? : No
Section Order : 635
Categories :
Tags :
Regions :
ViH Article Tags :